Caricamento...
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients with Atherosclerotic Renal Artery Stenosis
BACKGROUND: Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow (RBF) and amplifies stenotic kidney (SK) hypoxia. Revascularization with percutaneous transluminal renal angioplasty and stenting (PTRA) often fails to recover renal function possibly due to ischemia reperfusion injury...
Salvato in:
| Pubblicato in: | Circ Cardiovasc Interv |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659347/ https://ncbi.nlm.nih.gov/pubmed/28916603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005487 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|